Mettler-Toledo International, Inc. $MTD Stake Raised by Advisors Asset Management Inc.

Advisors Asset Management Inc. lifted its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTDFree Report) by 13.3% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,336 shares of the medical instruments supplier’s stock after purchasing an additional 157 shares during the quarter. Advisors Asset Management Inc.’s holdings in Mettler-Toledo International were worth $1,569,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in Mettler-Toledo International by 0.5% in the second quarter. Vanguard Group Inc. now owns 2,556,707 shares of the medical instruments supplier’s stock worth $3,003,415,000 after purchasing an additional 13,342 shares during the period. Bank of New York Mellon Corp boosted its stake in Mettler-Toledo International by 71.3% during the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock valued at $1,062,257,000 after buying an additional 376,419 shares in the last quarter. Alliancebernstein L.P. boosted its stake in Mettler-Toledo International by 21.6% during the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock valued at $837,653,000 after buying an additional 126,147 shares in the last quarter. Geode Capital Management LLC raised its position in Mettler-Toledo International by 0.6% in the second quarter. Geode Capital Management LLC now owns 581,847 shares of the medical instruments supplier’s stock worth $681,489,000 after acquiring an additional 3,383 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its holdings in Mettler-Toledo International by 5.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier’s stock valued at $568,032,000 after acquiring an additional 25,272 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on MTD shares. Robert W. Baird lifted their price target on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. Bank of America lifted their target price on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a report on Monday, September 22nd. Wells Fargo & Company boosted their target price on Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the stock an “equal weight” rating in a research report on Monday, November 10th. Stifel Nicolaus increased their price target on Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a research report on Monday, November 10th. Finally, Citigroup upped their price objective on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a research note on Monday, November 10th. Five research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $1,406.50.

Get Our Latest Stock Analysis on MTD

Insiders Place Their Bets

In other Mettler-Toledo International news, CEO Patrick Kaltenbach sold 2,000 shares of Mettler-Toledo International stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $1,462.50, for a total transaction of $2,925,000.00. Following the sale, the chief executive officer directly owned 3,670 shares of the company’s stock, valued at approximately $5,367,375. The trade was a 35.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Shawn Vadala sold 1,895 shares of the firm’s stock in a transaction that occurred on Tuesday, November 11th. The stock was sold at an average price of $1,455.52, for a total value of $2,758,210.40. Following the transaction, the chief financial officer owned 5,288 shares of the company’s stock, valued at $7,696,789.76. This trade represents a 26.38% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 19,565 shares of company stock valued at $28,683,737 in the last ninety days. 1.94% of the stock is currently owned by insiders.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD opened at $1,476.72 on Friday. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,525.17. The business’s 50-day simple moving average is $1,368.76 and its 200-day simple moving average is $1,273.86. The firm has a market cap of $30.17 billion, a price-to-earnings ratio of 37.39, a P/E/G ratio of 4.19 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTDGet Free Report) last released its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $997.36 million. During the same period in the prior year, the company earned $10.21 earnings per share. The business’s quarterly revenue was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. As a group, equities research analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

About Mettler-Toledo International

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Further Reading

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.